Skip to main content
. 2015 Jan 23;6(9):7280–7292. doi: 10.18632/oncotarget.3110

Figure 8. Effect of siRNA of DR3, DR6 and FAS on the BV induced cancer cell growth inhibition, and NF-κB activity in cervical cancer cells.

Figure 8

The cervical cancer cells were transfected with the DR3, DR6 and FAS siRNA (10 nM) for 24 hr, the cells were then and treated with BV (5 μg/ml) for 24 hr. After treatment, cell viability was measured by MTT assay (A, B) and NF-κB activity (C, D) determined as described above. Cell growths are means ± S.D. of three experiments. *(P < 0.05) indicates statistically significant differences from control group. #(P < 0.05) indicates statically significant differences from BV treated group.